{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:44:44Z","timestamp":1792896284792,"version":"4.5.0"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008775","name":"Mendel University in Brno","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phrs.2026.108317","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:35:59Z","timestamp":1782257759000},"page":"108317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Artesunate as an emerging anticancer modality: Insights and advances"],"prefix":"10.1016","volume":"230","author":[{"given":"Frantisek","family":"Petrlak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2881-800X","authenticated-orcid":false,"given":"Vendula","family":"Jemelikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5905-2603","authenticated-orcid":false,"given":"Anna","family":"Hanzlikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4827-5871","authenticated-orcid":false,"given":"Terezie","family":"Slesingerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-4336","authenticated-orcid":false,"given":"Yazan","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4942-4042","authenticated-orcid":false,"given":"Igor","family":"Opsenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-9409","authenticated-orcid":false,"given":"Jamile","family":"Taniele-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel Merlos","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/med.21657","article-title":"Artemisinin-derived antimalarial endoperoxides from bench-side to bed-side: Chronological advancements and future challenges","volume":"40","author":"Tiwari","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.176","article-title":"Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum","volume":"3","author":"Gao","year":"2024","journal-title":"Imeta"},{"key":"10.1016\/j.phrs.2026.108317_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100978","article-title":"Multi-omics dissection of stage-specific artemisinin tolerance mechanisms in Kelch13-mutant Plasmodium falciparum","volume":"70","author":"Chen","year":"2023","journal-title":"Drug. Resist. Updates"},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3892\/ol.2021.13011","article-title":"Progress on the study of the anticancer effects of artesunate","volume":"22","author":"Yang","year":"2021","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.phrs.2026.108317_bib6","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","article-title":"Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production","volume":"286","author":"Hamacher-Brady","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mco2.55","article-title":"Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment","volume":"2","author":"Liu","year":"2021","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib8","first-page":"114","article-title":"Potentiating sorafenib efficacy against hepatocellular carcinoma via a carrier-free nanomedicine of artesunate prodrug","volume":"5","author":"Liu","year":"2024","journal-title":"Smart Mater. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib9","first-page":"4735","article-title":"Artesunate and sorafenib: Combinatorial inhibition of liver cancer cell growth","volume":"18","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phrs.2026.108317_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154259","article-title":"Artesunate: A review of its therapeutic insights in respiratory diseases","volume":"104","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"issue":"15","key":"10.1016\/j.phrs.2026.108317_bib11","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.7150\/thno.115414","article-title":"Artemisiae Annuae Herba: from anti-malarial legacy to emerging anti-cancer potential","volume":"15","author":"Sun","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib12","first-page":"1","article-title":"significance of winning the 2015 Nobel Prize in Physiology or Medicine","volume":"6","author":"Liu","year":"2016","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.phrs.2026.108317_bib13","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.2147\/DDDT.S118116","article-title":"Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold","volume":"10","author":"Rudrapal","year":"2016","journal-title":"Drug. Des. Devel Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00706-016-1865-9","article-title":"A simplified and scalable synthesis of artesunate","volume":"148","author":"Presser","year":"2017","journal-title":"Mon. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2026.108317_bib15","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1142\/S0192415X22500847","article-title":"Arteannuin B Enhances the Effectiveness of Cisplatin in Non-Small Cell Lung Cancer by Regulating Connexin 43 and MAPK Pathway","volume":"50","author":"Huang","year":"2022","journal-title":"Am. J. Chin. Med."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib16","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1248\/bpb.b19-00391","article-title":"Artemether Attenuates the Progression of Non-small Cell Lung Cancer by Inducing Apoptosis, Cell Cycle Arrest and Promoting Cellular Senescence","volume":"42","author":"Chen","year":"2019","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.phrs.2026.108317_bib17","first-page":"2322","article-title":"Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria","volume":"3","author":"Li","year":"2010","journal-title":"Pharm. (Basel)"},{"issue":"11","key":"10.1016\/j.phrs.2026.108317_bib18","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.3390\/cimb46110718","article-title":"The Antiviral and Antimalarial Prodrug Artemisinin from the Artemisia Species: A Review","volume":"46","author":"Das","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108317_bib19","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s00436-020-06786-1","article-title":"Enhancing the antimalarial activity of artesunate","volume":"119","author":"Adebayo","year":"2020","journal-title":"Parasitol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2026.108317_bib20","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3004","article-title":"Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108317_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2018.05.008","article-title":"Prevention of carcinogenesis and metastasis by Artemisinin-type drugs","volume":"429","author":"Abba","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2026.108317_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175158","article-title":"Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling","volume":"930","author":"Lu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.phrs.2026.108317_bib23","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1039\/D3NJ00427A","article-title":"Novel artesunate\u2013pyrimidine-based hybrids with anticancer potential against multidrug-resistant cancer cells","volume":"47","author":"Kora\u010dak","year":"2023","journal-title":"New. J. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108702","article-title":"A mitochondria-targeting dihydroartemisinin derivative as a reactive oxygen species -based immunogenic cell death inducer","volume":"27","author":"Zhao","year":"2024","journal-title":"iScience"},{"issue":"29","key":"10.1016\/j.phrs.2026.108317_bib25","doi-asserted-by":"crossref","first-page":"17270","DOI":"10.1039\/D0RA02150D","article-title":"vivo and in vitro evaluation of dihydroartemisinin prodrug nanocomplexes as a nano-drug delivery system: characterization, pharmacokinetics and pharmacodynamics","volume":"10","author":"Ren","year":"2020","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12951-021-01200-z","article-title":"A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnology"},{"issue":"43","key":"10.1016\/j.phrs.2026.108317_bib27","doi-asserted-by":"crossref","first-page":"38832","DOI":"10.1021\/acsomega.2c04562","article-title":"Synthesis and Antitumor Activities of Novel Mitochondria-Targeted Dihydroartemisinin Ether Derivatives","volume":"7","author":"Xu","year":"2022","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41392-021-00671-8","article-title":"A new paradigm for artesunate anticancer function: considerably enhancing the cytotoxicity via conjugating artesunate with aptamer","volume":"6","author":"Li","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2026.108317_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107733","article-title":"Design, synthesis and biological evaluation of artesunate-Se derivatives as anticancer agents by inducing GPX4-mediated ferroptosis","volume":"152","author":"Ren","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2026.108317_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.570","article-title":"A platinum(IV)\u2013artesunate complex triggers ferroptosis by boosting cytoplasmic and mitochondrial lipid peroxidation to enhance tumor immunotherapy","volume":"5","author":"Fan","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.phrs.2026.108317_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2025.123804","article-title":"Organometallic conjugates of artesunate: synthesis and evaluation of anticancer potential","volume":"1039","author":"van der Merwe","year":"2025","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.phrs.2026.108317_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103686","article-title":"Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer","volume":"84","author":"Chen","year":"2025","journal-title":"Redox Biol."},{"issue":"22","key":"10.1016\/j.phrs.2026.108317_bib33","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2174\/1568026616666160212122820","article-title":"Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma","volume":"16","author":"Ilamathi","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jcmm.14717","article-title":"Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence","volume":"24","author":"Wei","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.phrs.2026.108317_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"Efferth","year":"2007","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mc.22474","article-title":"Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate","volume":"56","author":"Greenshields","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib37","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/15384047.2015.1071738","article-title":"Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51","volume":"16","author":"Wang","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phrs.2026.108317_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107526","article-title":"Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma","volume":"210","author":"Liu","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108317_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9591544","article-title":"New Insights into Artesunate as a Pleiotropic Regulator of Innate and Adaptive Immune Cells","volume":"2022","author":"Lin","year":"2022","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70076","article-title":"Artesunate Suppresses the Migration and Invasion of Thyroid Cancer Cells via Upregulating PTEN to Block M2 Polarization of Tumor-Associated Macrophages","volume":"105","author":"Xu","year":"2025","journal-title":"Chem. Biol. Drug. Des."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib41","first-page":"279","article-title":"Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-\u03baB and PI3K\/Akt signaling pathways","volume":"39","author":"Thanaketpaisarn","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.phrs.2026.108317_bib42","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/OTT.S81041","article-title":"Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2","volume":"8","author":"Zhang","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.phrs.2026.108317_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152968","article-title":"Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-kappaB signaling","volume":"63","author":"Su","year":"2019","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.phrs.2026.108317_bib44","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.3390\/ijms150814298","article-title":"Artesunate Induces Apoptosis of Bladder Cancer Cells by miR-16 Regulation of COX-2 Expression","volume":"15","author":"Zuo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164838","article-title":"Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/cbin.10244","article-title":"Artesunate exerts an anti-immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression","volume":"38","author":"Zhang","year":"2014","journal-title":"Cell. Biol. Int."},{"key":"10.1016\/j.phrs.2026.108317_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yexmp.2019.01.006","article-title":"The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells","volume":"107","author":"Greenshields","year":"2019","journal-title":"Exp. Mol. Pathol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib48","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1177\/0960327120937331","article-title":"Antimalarial agent artesunate induces G0\/G1 cell cycle arrest and apoptosis via increasing intracellular ROS levels in normal liver cells","volume":"39","author":"Yin","year":"2020","journal-title":"Human. & Exp. Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108317_bib49","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/CAD.0000000000000089","article-title":"Artesunate induces G2\/M cell cycle arrest through autophagy induction in breast cancer cells","volume":"25","author":"Chen","year":"2014","journal-title":"Anticancer. Drugs"},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib50","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1158\/1535-7163.MCT-11-0534","article-title":"Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM\/ATR damage response in cancer cells","volume":"10","author":"Berdelle","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.phrs.2026.108317_bib51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12282-018-0873-5","article-title":"Artesunate promotes G2\/M cell cycle arrest in MCF7 breast cancer cells through ATM activation","volume":"25","author":"Wen","year":"2018","journal-title":"Breast Cancer"},{"key":"10.1016\/j.phrs.2026.108317_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172953","article-title":"Evaluation of artesunate for the treatment of adult T-cell leukemia\/lymphoma","volume":"872","author":"Ishikawa","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib53","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20197992","article-title":"Artesunate promotes Th1 differentiation from CD4+ T cells to enhance cell apoptosis in ovarian cancer via miR-142","volume":"52","author":"Chen","year":"2019","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"8","key":"10.1016\/j.phrs.2026.108317_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329490","article-title":"Artesunate regulates malignant progression of breast cancer cells via lncRNA TUG1\/miR-145-5p\/HOXA5 axis","volume":"20","author":"Yang","year":"2025","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/mc.22296","article-title":"Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells","volume":"55","author":"Hargraves","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"11","key":"10.1016\/j.phrs.2026.108317_bib56","doi-asserted-by":"crossref","first-page":"18260","DOI":"10.18632\/oncotarget.15353","article-title":"Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108317_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-026-04323-1","article-title":"Artesunate directly targeting MMP9 to reduce angiogenesis and increase CD8\u2009+\u2009T cell infiltration inhibits hepatocellular carcinoma","author":"Wang","year":"2026","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.phrs.2026.108317_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/454783","article-title":"Synergistic inhibition of angiogenesis by artesunate and captopril in vitro and in vivo","volume":"2013","author":"Krusche","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000076256","article-title":"Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR\/flk-1","volume":"71","author":"Chen","year":"2004","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib60","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s43440-021-00230-6","article-title":"Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway","volume":"73","author":"Berk\u00f6z","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib61","first-page":"6170","article-title":"Artesunate inhibits proliferation and invasion of mouse hemangioendothelioma cells in vitro and of tumor growth in vivo","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib62","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3892\/ijmm.2017.3085","article-title":"Anti-angiogenic properties of artemisinin derivatives (Review)","volume":"40","author":"Wei","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib63","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027530","article-title":"Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats","volume":"15","author":"Wang","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2026.108317_bib64","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Rasheed","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00296-009-1218-7","article-title":"The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1\u03b1 in human rheumatoid arthritis fibroblast-like synoviocyte","volume":"31","author":"He","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"9","key":"10.1016\/j.phrs.2026.108317_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097844","article-title":"Anti-Cancer Effects of Artesunate in Human 3D Tumor Models of Different Complexity","volume":"24","author":"Niederreiter","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib67","article-title":"Artesunate inhibits vasculogenic mimicry in choroidal melanoma through HIF-1 \u03b1\/ VEGF\/PDGF pathway","volume":"126","author":"Ma","year":"2024","journal-title":"Acta Histochem."},{"issue":"32","key":"10.1016\/j.phrs.2026.108317_bib68","doi-asserted-by":"crossref","first-page":"33046","DOI":"10.18632\/oncotarget.5422","article-title":"Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis","volume":"6","author":"Jeong","year":"2015","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.phrs.2026.108317_bib69","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1111\/febs.16046","article-title":"The gate to metastasis: key players in cancer cell intravasation","volume":"289","author":"Sznurkowska","year":"2022","journal-title":"Febs J."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib70","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/21655979.2020.1834727","article-title":"Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7","volume":"11","author":"Wang","year":"2020","journal-title":"Bioengineered"},{"key":"10.1016\/j.phrs.2026.108317_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108859","article-title":"Artesunate inhibits the development of PVR by suppressing the TGF-\u03b2\/Smad signaling pathway","volume":"213","author":"Wang","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41556-018-0195-z","article-title":"Mesenchymal\u2013epithelial transition in development and reprogramming","volume":"21","author":"Pei","year":"2019","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41598-023-50710-3","article-title":"Mesenchymal\u2013epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate","volume":"14","author":"Terragno","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41392-025-02305-9","article-title":"DDX39B K63-linked ubiquitination mediated by TRIM28 promotes NSCLC metastasis by enhancing ECAD lysosomal degradation","volume":"10","author":"Yuan","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yexcr.2016.06.012","article-title":"Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells","volume":"347","author":"Pang","year":"2016","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","article-title":"The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy","volume":"10","author":"Vogler","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2026.108317_bib77","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/bph.15986","article-title":"Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS\/Bim and TFRC\/Fe(2+) pathways","volume":"180","author":"Liu","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib78","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yexcr.2015.07.004","article-title":"Artesunate induces apoptosis via a ROS-independent and Bax-mediated intrinsic pathway in HepG2 cells","volume":"336","author":"Qin","year":"2015","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib79","doi-asserted-by":"crossref","first-page":"22383","DOI":"10.1038\/s41598-023-49928-y","article-title":"Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells","volume":"13","author":"Hill","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib80","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.cdd.4402028","article-title":"Apoptosome: a platform for the activation of initiator caspases","volume":"14","author":"Bao","year":"2007","journal-title":"Cell. Death & Differ."},{"issue":"30","key":"10.1016\/j.phrs.2026.108317_bib81","doi-asserted-by":"crossref","first-page":"30017","DOI":"10.18632\/oncotarget.5013","article-title":"Bax-PGAM5L-Drp1 complex is required for intrinsic apoptosis execution","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.phrs.2026.108317_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221838","article-title":"Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications","volume":"13","author":"Mustafa","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib83","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3892\/mmr.2015.3517","article-title":"Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2026.108317_bib84","article-title":"Artesunate-binding FABP5 promotes apoptosis in lung cancer cells via the PPAR\u03b3-SCD pathway","volume":"143","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15171\/ijb.1567","article-title":"Induction of Apoptosis in Human Breast Cancer MCF-7 Cells by a Semi-Synthetic Derivative of Artemisinin: A Caspase-Related Mechanism","volume":"15","author":"Jamalzadeh","year":"2017","journal-title":"Iran. J. Biotechnol."},{"key":"10.1016\/j.phrs.2026.108317_bib86","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.ijbiomac.2020.08.198","article-title":"Artesunate, as a HSP70 ATPase activity inhibitor, induces apoptosis in breast cancer cells","volume":"164","author":"Pirali","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib87","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1248\/bpb.b16-00908","article-title":"Artesunate Suppresses the Growth of Prostatic Cancer Cells through Inhibiting Androgen Receptor","volume":"40","author":"Wang","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"48","key":"10.1016\/j.phrs.2026.108317_bib88","doi-asserted-by":"crossref","first-page":"33425","DOI":"10.1074\/jbc.M114.564567","article-title":"Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin","volume":"289","author":"Yang","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib89","first-page":"691","article-title":"Artesunate induces ER-derived-ROS-mediated cell death by disrupting labile iron pool and iron redistribution in hepatocellular carcinoma cells","volume":"11","author":"Jiang","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib90","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41401-020-0445-z","article-title":"Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib91","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: Regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.phrs.2026.108317_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.578418","article-title":"The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity","volume":"10","author":"Chavez-Dominguez","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108317_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109273","article-title":"Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells","volume":"331","author":"Zhou","year":"2020","journal-title":"Chem. -Biol. Interact."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00630-22","article-title":"Autophagy Underlies the Proteostasis Mechanisms of Artemisinin Resistance in P. falciparum Malaria","volume":"13","author":"Ray","year":"2022","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.phrs.2026.108317_bib95","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s12276-022-00780-6","article-title":"Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic degradation","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. & Mol. Med."},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib96","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/abbs\/gmy125","article-title":"Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"issue":"8","key":"10.1016\/j.phrs.2026.108317_bib97","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.phrs.2026.108317_bib98","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41419-023-05978-8","article-title":"Autophagy mediates an amplification loop during ferroptosis","volume":"14","author":"Lee","year":"2023","journal-title":"Cell. Death & Dis."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib99","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3164\/jcbn.21-82","article-title":"Intracellular ferritin heavy chain plays the key role in artesunate-induced ferroptosis in ovarian serous carcinoma cells","volume":"71","author":"Koike","year":"2022","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.phrs.2026.108317_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110167","article-title":"Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling","volume":"88","author":"Chen","year":"2021","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib101","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/ol.2024.14447","article-title":"Artesunate promotes cervical cancer cell apoptosis by regulating Bcl2 family molecules and reducing the mitochondrial membrane potential","volume":"28","author":"Zhang","year":"2024","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib102","first-page":"1295","article-title":"Artesunate induces apoptosis and autophagy in HCT116 colon cancer cells, and autophagy inhibition enhances the artesunate\u2011induced apoptosis","volume":"42","author":"Jiang","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib103","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib104","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12964-024-01759-8","article-title":"Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1","volume":"22","author":"Liu","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.phrs.2026.108317_bib105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","article-title":"Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis","volume":"11","author":"Roh","year":"2017","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib106","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.7150\/ijms.86409","article-title":"Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells","volume":"20","author":"Liang","year":"2023","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib107","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jphs.2022.01.007","article-title":"Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells","volume":"148","author":"Song","year":"2022","journal-title":"J. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib108","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18632\/oncoscience.160","article-title":"Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells","volume":"2","author":"Eling","year":"2015","journal-title":"Oncoscience"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib109","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41419-025-07822-7","article-title":"Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2","volume":"16","author":"Liu","year":"2025","journal-title":"Cell. Death & Dis."},{"issue":"7","key":"10.1016\/j.phrs.2026.108317_bib110","article-title":"Artesunate induces ferroptosis in osteosarcoma through NCOA4-mediated ferritinophagy. Faseb j","volume":"39","author":"Huang","year":"2025"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib111","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12957-024-03544-w","article-title":"Inhibition of HOXC11 by artesunate induces ferroptosis and suppresses ovarian cancer progression through transcriptional regulation of the PROM2\/PI3K\/AKT pathway","volume":"22","author":"Li","year":"2024","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib112","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/0113816128289372240105041038","article-title":"Artesunate Inhibits the Growth of Insulinoma Cells via SLC7A11\/ GPX4-mediated Ferroptosis","volume":"30","author":"Fengping","year":"2024","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib113","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","article-title":"Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib114","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8584","article-title":"Artesunate synergistically promotes sorafenib\u2011induced apoptosis and ferroptosis in non\u2011Hodgkin lymphoma cells through inhibition of the STAT3 pathway","volume":"50","author":"Chen","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2026.108317_bib115","article-title":"Unravelling oncosis: morphological and molecular insights into a unique cell death pathway","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib116","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","article-title":"Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo","volume":"65","author":"Du","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108317_bib117","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/CAD.0b013e328364a109","article-title":"Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo","volume":"24","author":"Zhou","year":"2013","journal-title":"Anticancer. Drugs"},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib118","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.7314\/APJCP.2013.14.12.7069","article-title":"Connections between various trigger factors and the RIP1\/ RIP3 signaling pathway involved in necroptosis","volume":"14","author":"Zhang","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.434","article-title":"Artesunate induces necrotic cell death in schwannoma cells","volume":"5","author":"Button","year":"2014","journal-title":"Cell. Death & Dis."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11010-017-3052-7","article-title":"RIP1-dependent reactive oxygen species production executes artesunate-induced cell death in renal carcinoma Caki cells","volume":"435","author":"Chauhan","year":"2017","journal-title":"Mol. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.phrs.2026.108317_bib121","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/cancers16071321","article-title":"Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer","volume":"16","author":"McCorkle","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib122","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12951-022-01676-3","article-title":"Synergetic delivery of artesunate and isosorbide 5-mononitrate with reduction-sensitive polymer nanoparticles for ovarian cancer chemotherapy","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnology"},{"issue":"83","key":"10.1016\/j.phrs.2026.108317_bib123","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.1039\/C8CC06576D","article-title":"Towards rational design of RAD51-targeting prodrugs: platinum<SUP>IV<\/SUP>-artesunate conjugates with enhanced cytotoxicity against BRCA-proficient ovarian and breast cancer cells","volume":"54","author":"Zhang","year":"2018","journal-title":"Chem. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib124","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3892\/ol.2021.12858","article-title":"Artesunate combined with verteporfin inhibits uveal melanoma by regulation of the <em>MALAT1<\/em>\/yes\u2011associated protein signaling pathway","volume":"22","author":"Jiu","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phrs.2026.108317_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1448381","article-title":"Integrating network pharmacology, molecular docking and experimental verification to reveal the mechanism of artesunate in inhibiting choroidal melanoma","volume":"15","author":"Ma","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib126","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8591","article-title":"Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate-induced decreases in Rb and phosphorylated Rb levels","volume":"50","author":"Okamoto","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2026.108317_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.789284","article-title":"Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells","volume":"12","author":"Vakhrusheva","year":"2022","journal-title":"Front. Oncol."},{"issue":"19","key":"10.1016\/j.phrs.2026.108317_bib128","article-title":"Artesunate inhibits multiple proinflammatory transcription factors leading to the suppression of growth and induction of apoptosis in prostate cancer cells","volume":"74","author":"Nachiyappan","year":"2014","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neo.2017.02.002","article-title":"Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens","volume":"19","author":"Nunes","year":"2017","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.phrs.2026.108317_bib130","first-page":"1298","article-title":"The Anti-Angiogenesis Effects of Artesunate Liposomes on Human Hepatocellular Carcinoma Cell Lines","volume":"34","author":"Shen","year":"2015","journal-title":"Lat. Am. J. Pharm."},{"issue":"3-4","key":"10.1016\/j.phrs.2026.108317_bib131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10717544.2013.801047","article-title":"vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice","volume":"20","author":"Jin","year":"2013","journal-title":"Drug. Deliv."},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib132","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41401-020-0395-5","article-title":"Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells","volume":"41","author":"Yao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib133","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bcp.2009.04.014","article-title":"Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells","volume":"78","author":"Youns","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108317_bib134","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2147\/DDDT.S199459","article-title":"Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells","volume":"13","author":"Wang","year":"2019","journal-title":"Drug. Des. Devel Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1139\/bcb-2021-0275","article-title":"Artesunate inhibits proliferation, migration, and invasion of thyroid cancer cells by regulating the PI3K\/AKT\/FKHR pathway","volume":"100","author":"Xu","year":"2022","journal-title":"Biochem. Cell. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib136","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/21655979.2020.1834727","article-title":"Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7","volume":"11","author":"Wang","year":"2020","journal-title":"Bioengineered"},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib137","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcp.2009.08.013","article-title":"Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines","volume":"79","author":"Michaelis","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib138","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3892\/or.2016.4847","article-title":"Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties","volume":"36","author":"Lian","year":"2016","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib139","first-page":"1819","article-title":"Safety and efficacy field study of artesunate for dogs with non-resectable tumours","volume":"33","author":"Rutteman","year":"2013","journal-title":"Anticancer. Res."},{"issue":"8","key":"10.1016\/j.phrs.2026.108317_bib140","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3109\/21691401.2015.1129616","article-title":"Enhancing activity of artesunate against breast cancer cells via induced-apoptosis pathway by loading into lipid carriers","volume":"44","author":"Tran","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib141","first-page":"368","article-title":"Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo","volume":"11","author":"Safdarian","year":"2024","journal-title":"Nanomed. J."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21873\/cgp.20300","article-title":"Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells","volume":"19","author":"Zadeh","year":"2022","journal-title":"Cancer Genom. - Proteom."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib143","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12951-022-01569-5","article-title":"Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy","volume":"20","author":"Gu","year":"2022","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib144","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1186\/s12885-017-3863-7","article-title":"Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment","volume":"17","author":"Kumari","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phrs.2026.108317_bib145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2019.01.041","article-title":"Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo","volume":"70","author":"Cao","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib146","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3892\/ijmm.2012.1176","article-title":"Involvement of the mitochondrial pathway and Bim\/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro","volume":"31","author":"Mao","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib147","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0b013e32834f6ea8","article-title":"Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes","volume":"23","author":"Tin","year":"2012","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.phrs.2026.108317_bib148","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0960-7","article-title":"Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF- signaling in breast cancer","volume":"37","author":"Yao","year":"2018","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib149","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1038\/s41598-017-08058-y","article-title":"Connexin-43 enhances tumor suppressing activity of artesunate via gap junction-dependent as well as independent pathways in human breast cancer cells","volume":"7","author":"Raza","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib150","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.apsb.2019.05.001","article-title":"Synergistic antitumor activity of artesunate and HDAC inhibitors through elevating heme synthesis via synergistic upregulation of ALAS1 expression","volume":"9","author":"Chen","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib151","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10637-020-00996-1","article-title":"The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma","volume":"39","author":"Ishikawa","year":"2021","journal-title":"Invest. New. Drugs"},{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib152","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jha2.314","article-title":"Artemisinins induce endoplasmic reticulum stress in acute leukaemia cells in vitro and in vivo","volume":"2","author":"Mancuso","year":"2021","journal-title":"EJHaem"},{"key":"10.1016\/j.phrs.2026.108317_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110167","article-title":"Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling","volume":"88","author":"Chen","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2026.108317_bib154","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cbi.2017.10.011","article-title":"Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of \u03b2-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis","volume":"278","author":"Verma","year":"2017","journal-title":"Chem. -Biol. Interact."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2015.05.004","article-title":"Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor \u03b21 and interleukin-10","volume":"27","author":"Cui","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108317_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111108","article-title":"Artesunate-loaded solid lipid nanoparticles resist esophageal squamous cell carcinoma by inducing Ferroptosis through inhibiting the AKT\/mTOR signaling","volume":"117","author":"Xia","year":"2024","journal-title":"Cell. Signal."},{"issue":"14","key":"10.1016\/j.phrs.2026.108317_bib157","doi-asserted-by":"crossref","first-page":"858","DOI":"10.21037\/atm-20-1113","article-title":"Artesunate exerts anti-prolactinoma activity by inhibiting mitochondrial metabolism and inducing apoptosis","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib158","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1007\/s11033-011-1442-6","article-title":"Artesunate inhibits cell proliferation and decreases growth hormone synthesis and secretion in GH3 cells","volume":"39","author":"Mao","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib159","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2019.12.035","article-title":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3)","volume":"157","author":"Trimble","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108317_bib160","first-page":"1599","article-title":"Artesunate in the treatment of metastatic uveal melanoma - first experiences","volume":"14","author":"Berger","year":"2005","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib161","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib162","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00280-016-2960-7","article-title":"Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study","volume":"77","author":"K\u00f6nig","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib163","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2)","volume":"164","author":"von Hagens","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2026.108317_bib164","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phymed.2018.09.178","article-title":"Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33\/2)","volume":"54","author":"von Hagens","year":"2019","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib165","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00228-014-1754-2","article-title":"Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer","volume":"70","author":"Ericsson","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108317_bib166","unstructured":"A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Vaginal Inserts for the Treatment of Patients With Cervical Intraepithelial Neoplasia (CIN2\/3), R. Amarex Clinical, et al., Editors. 2019."},{"key":"10.1016\/j.phrs.2026.108317_bib167","unstructured":"A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Ointment for the Treatment of HIV-negative Patients With Anal High-grade Squamous Intraepithelial Lesions (Anal HSIL), L.L.C. Laser Surgery Care and M. Anal Dysplasia Clinic, Editors. 2024."},{"key":"10.1016\/j.phrs.2026.108317_bib168","unstructured":"A Phase II Double-blind, Placebo-controlled, Randomized Trial of Topical Artesunate Ointment for the Treatment of Patients With Vulvar High-grade Squamous Intraepithelial Lesions (Vulvar HSIL), C. The Cleveland, Editor. 2023."},{"key":"10.1016\/j.phrs.2026.108317_bib169","unstructured":"Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya, I. National Cancer, I. Kenya Medical Research, and K. Maseno University School of Medicine, Editors. 2024."},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib170","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1080\/03639045.2017.1357729","article-title":"Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response","volume":"43","author":"Tran","year":"2017","journal-title":"Drug. Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib171","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1734-1140(13)71021-1","article-title":"Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells","volume":"65","author":"Wu","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"41","key":"10.1016\/j.phrs.2026.108317_bib172","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/eurheartj\/ehs100","article-title":"Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression","volume":"34","author":"Oelze","year":"2013","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib173","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/acs.jmedchem.9b01456","article-title":"Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology","volume":"63","author":"Borsari","year":"2020","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.phrs.2026.108317_bib174","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1021\/acs.jmedchem.9b00359","article-title":"Overview of Recent Strategic Advances in Medicinal Chemistry","volume":"62","author":"Wu","year":"2019","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bmcl.2014.10.048","article-title":"The biological characteristics of a novel camptothecin\u2013artesunate conjugate","volume":"25","author":"Li","year":"2015","journal-title":"Bioorg. & Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2026.108317_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113000","article-title":"Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers","volume":"211","author":"Zhou","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202400373","article-title":"Hybrid Molecules Containing Methotrexate, Vitamin D, and Platinum Derivatives: Synthesis, Characterization, In Vitro Cytotoxicity, In Silico ADME Docking, Molecular Docking and Dynamics","volume":"22","author":"Mbese","year":"2025","journal-title":"Chem. & Biodivers."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib178","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/acsmedchemlett.0c00131","article-title":"Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1","volume":"11","author":"Botta","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2026.108317_bib179","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","article-title":"Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment","volume":"5","author":"Elumalai","year":"2024","journal-title":"Biomed. Technol."},{"key":"10.1016\/j.phrs.2026.108317_bib180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","article-title":"Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance","volume":"7","author":"Yao","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.phrs.2026.108317_bib181","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1296091","article-title":"Lipid-based nanoparticles as drug delivery carriers for cancer therapy","volume":"14","author":"Waheed","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108317_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114841","article-title":"Carrier free nano-assembled redox dual-responsive biotin-artesunate conjugate for enhanced tumor therapy","volume":"215","author":"Liu","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.phrs.2026.108317_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121138","article-title":"Dimeric artesunate-choline conjugate micelles coated with hyaluronic acid as a stable, safe and potent alternative anti-malarial injection of artesunate","volume":"609","author":"He","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2026.108317_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122822","article-title":"Local delivery of artesunate dimer liposomes incorporated injectable hydrogel for H2O2 and pH-independent chemodynamic therapy","volume":"636","author":"Wang","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib185","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.1016\/j.ceramint.2022.01.223","article-title":"Surfactant free-poly(lactic-co-glycolic acid) coated artesunate loaded citrate-functionalized hydroxyapatite nanorods as a nanocapsule for improving artesunate delivery and antitumor efficiency","volume":"48","author":"Salahuddin","year":"2022","journal-title":"Ceram. Int."},{"issue":"7","key":"10.1016\/j.phrs.2026.108317_bib186","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1080\/03639045.2017.1300163","article-title":"Development of electrosprayed artesunate-loaded core\u2013shell nanoparticles","volume":"43","author":"Ho","year":"2017","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.phrs.2026.108317_bib187","first-page":"737","article-title":"Inhibition of ARH2 by pH\/ROS-responsive nanosystem for improved lung adenocarcinoma immunochemotherapy","volume":"53","author":"Cai","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.phrs.2026.108317_bib188","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.actbio.2022.03.051","article-title":"NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy","volume":"145","author":"Zhong","year":"2022","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib189","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1021\/acsabm.0c00632","article-title":"Amplified Activity of Artesunate Mediated by Iron Oxide Nanoparticles Loaded on a Graphene Oxide Carrier for Cancer Therapeutics","volume":"3","author":"Yadav","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.phrs.2026.108317_bib190","first-page":"1185","article-title":"Effect of interaction of magnetic nanoparticles of Fe\u2083O\u2084 and artesunate on apoptosis of K562 cells","volume":"6","author":"Wang","year":"2011","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib191","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s12272-014-0424-3","article-title":"Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles","volume":"38","author":"Nguyen","year":"2015","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib192","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1038\/s41598-022-08627-w","article-title":"Hyaluronic acid functionalized ZnO nanoparticles co-deliver AS and GOD for synergistic cancer starvation and oxidative damage","volume":"12","author":"Ren","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib193","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s11671-018-2700-5","article-title":"Artesunate-Loaded and Near-Infrared Dye-Conjugated Albumin Nanoparticles as High-Efficiency Tumor-Targeted Photo-Chemo Theranostic Agent","volume":"13","author":"Yang","year":"2018","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.phrs.2026.108317_bib194","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijbiomac.2021.03.124","article-title":"Artesunate-loaded poly (lactic-co-glycolic acid)\/polydopamine-manganese oxides nanoparticles as an oxidase mimic for tumor chemo-catalytic therapy","volume":"181","author":"Xi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib195","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3892\/etm.2023.12215","article-title":"Evaluation of the liver targeting and anti\u2011liver cancer activity of artesunate\u2011loaded and glycyrrhetinic acid\u2011coated nanoparticles","volume":"26","author":"Pan","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phrs.2026.108317_bib196","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/IJN.S444076","article-title":"Artesunate-Nanoliposome-TPP, a Novel Drug Delivery System That Targets the Mitochondria, Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Oxidative Stress and Inflammatory Effects","volume":"19","author":"Zhang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2026.108317_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122675","article-title":"situ hydrogel based on Cu\u2013Fe3O4 nanoclusters exploits oxidative stress and the ferroptosis\/cuproptosis pathway for chemodynamic therapy","volume":"311","author":"Zhang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.108317_bib198","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-026-04381-7","article-title":"MnUA\u2013DOX\u2013artesunate hydrogel remodels immunosuppressive tumor microenvironment and prevents postoperative recurrence in triple-negative breast cancer","author":"Cai","year":"2026","journal-title":"J. Nanobiotechnology"},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib199","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1021\/acs.molpharmaceut.1c00500","article-title":"Dimeric Artesunate-Phosphatidylcholine-Based Liposomes for Irinotecan Delivery as a Combination Therapy Approach","volume":"18","author":"He","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2026.108317_bib200","article-title":"Revolution in cancer treatment methods: Perspective review of factors affecting the final results of nanoparticles used in magnetic fluid hyperthermia","volume":"14","author":"Oskoui","year":"2025","journal-title":"Health Sci. Rev."},{"key":"10.1016\/j.phrs.2026.108317_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.150625","article-title":"Programming self-assembling magnetic microrobots with multiple physical and chemical intelligence","volume":"488","author":"Mayorga-Martinez","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/j.phrs.2026.108317_bib202","first-page":"1647","article-title":"Magnetic Nanoparticles of Fe3O4 Enhance Artesunate-inducing Apoptosis of SKM-1 Cells","volume":"23","author":"Wang","year":"2015","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib203","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/acs.biomac.2c01300","article-title":"Design of an Injectable Magnetic Hydrogel Based on the Tumor Microenvironment for Multimodal Synergistic Cancer Therapy","volume":"24","author":"Ma","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2026.108317_bib204","article-title":"Magnetic CuFe(2)O(4) with intrinsic protease-like activity inhibited cancer cell proliferation and migration through mediating intracellular proteins","volume":"5","author":"Chen","year":"2022","journal-title":"Biomater. Biosyst."},{"issue":"13","key":"10.1016\/j.phrs.2026.108317_bib205","doi-asserted-by":"crossref","first-page":"14884","DOI":"10.1021\/acsami.0c00970","article-title":"Tumor-Specific Endogenous Fe(II)-Activated, MRI-Guided Self-Targeting Gadolinium-Coordinated Theranostic Nanoplatforms for Amplification of ROS and Enhanced Chemodynamic Chemotherapy","volume":"12","author":"Fan","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.phrs.2026.108317_bib206","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0316334","article-title":"Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya","volume":"20","author":"Mungo","year":"2025","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib207","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12936-024-05085-9","article-title":"Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers","volume":"23","author":"Tarning","year":"2024","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.phrs.2026.108317_bib208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmpb.2013.05.010","article-title":"Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisinin","volume":"112","author":"Hall","year":"2013","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.phrs.2026.108317_bib209","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/1475-2875-13-478","article-title":"The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine","volume":"13","author":"Zang","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.phrs.2026.108317_bib210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1475-2875-10-263","article-title":"Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration","volume":"10","author":"Morris","year":"2011","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.phrs.2026.108317_bib211","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","article-title":"A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies","volume":"81","author":"Deeken","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108317_bib212","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1021\/acsomega.9b04140","article-title":"Quantum Chemical Lipophilicities of Antimalarial Drugs in Relation to Terminal Half-Life","volume":"5","author":"Alia","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.phrs.2026.108317_bib213","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijid.2019.08.030","article-title":"Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria","volume":"89","author":"Kouakou","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.phrs.2026.108317_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155274","article-title":"Artesunate in glioblastoma therapy: Case reports and review of clinical studies","volume":"123","author":"Strik","year":"2024","journal-title":"Phytomedicine"},{"issue":"1-2","key":"10.1016\/j.phrs.2026.108317_bib215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2000.63.48","article-title":"Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients","volume":"63","author":"Kissinger","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"9","key":"10.1016\/j.phrs.2026.108317_bib216","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12032-023-02138-y","article-title":"Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role","volume":"40","author":"Kannampuzha","year":"2023","journal-title":"Med. Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib217","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.6004\/jnccn.2019.7305","article-title":"Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes","volume":"17","author":"Smith","year":"2019","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"10","key":"10.1016\/j.phrs.2026.108317_bib218","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib219","article-title":"Mechanisms of acquired tumor drug resistance","volume":"1872","author":"Aleksakhina","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA)"},{"issue":"2","key":"10.1016\/j.phrs.2026.108317_bib220","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug. Resist."},{"issue":"5","key":"10.1016\/j.phrs.2026.108317_bib221","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020550","article-title":"Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells","volume":"6","author":"Bachmeier","year":"2011","journal-title":"PLoS. One"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:06:44Z","timestamp":1785074804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182600232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":221,"alternative-id":["S104366182600232X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108317","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate as an emerging anticancer modality: Insights and advances","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108317"}}